Fundraising FoxSimbiosys
Chicago, US · Founded 2018 · Delaware corporation · 5 known investors
Find your way into Simbiosys
Sign up to see every warm intro you have to Simbiosys
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Simbiosys team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
Founders & leadership
Simbiosys was founded in 2018 by Joe Peterson, John Cole, and Tushar Pandey.
Board
Investors · 5
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Genoa Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kleinmuntz Associates's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.1M disclosed across 2 rounds · 2018–2024
▶$5.2MraisedJan 2025 · 13 investors · BiotechnologyRule 506(b)
- Lucy CoassinDirector
- Vikram ChaudheryDirector
- Ronnie AndrewsDirector
- William HyunDirector
- Joseph PetersonExecutive Officer, Director
- Stacey StevensExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · 3 investors · BiotechnologyRule 506(b)
- John A ColeExecutive Officer
- Joseph R PetersonExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $900K
- Minimum investment
- $50K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Simbiosys do?
- SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
- Who founded Simbiosys?
- Simbiosys was founded by Joe Peterson, John Cole, Tushar Pandey in 2018.
- Who are Simbiosys's investors?
- Simbiosys's investors include AV8 Ventures, Genoa Ventures, Kleinmuntz Associates, GENERAL INCEPTION, Northpond Ventures.
- How much funding has Simbiosys raised?
- Simbiosys has disclosed $6.1M raised across 2 rounds.
- Where is Simbiosys headquartered?
- Simbiosys is headquartered in Chicago, US.